These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 30034638)

  • 21. Correction: Transforming growth factor β-induced epithelial-to-mesenchymal signature predicts metastasis-free survival in non-small cell lung cancer.
    Gordian E; Welsh EA; Gimbrone N; Siegel EM; Shibata D; Creelan BC; Cress WD; Eschrich SA; Haura EB; Muñoz-Antonia T
    Oncotarget; 2021 Jun; 12(13):1325. PubMed ID: 34194632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correction: Prediction of survival prognosis of non-small cell lung cancer by APE1 through regulation of epithelial-mesenchymal transition.
    Wei X; Li Q; Li Y; Duan W; Huang C; Zheng X; Sun L; Luo J; Wang D; Zhang S; Xin X; Gao M
    Oncotarget; 2022; 13():118-119. PubMed ID: 35035777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correction: SNiPER: a novel hypermethylation biomarker panel for liquid biopsy based early breast cancer detection.
    Mijnes J; Tiedemann J; Eschenbruch J; Gasthaus J; Bringezu S; Bauerschlag D; Maass N; Arnold N; Weimer J; Anzeneder T; Fasching PA; Rübner M; Bruno B; Heindrichs U; Freres J; Schulz H; Hilgers RD; Ortiz-Brüchle N; von Serenyi S; Knüchel R; Kloten V; Dahl E
    Oncotarget; 2020 Jul; 11(30):2958. PubMed ID: 32774775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correction: Cytochrome P450 1B1 inhibition suppresses tumorigenicity of prostate cancer
    Chang I; Mitsui Y; Kim SK; Sun JS; Jeon HS; Kang JY; Kang NJ; Fukuhara S; Gill A; Shahryari V; Tabatabai ZL; Greene KL; Dahiya R; Shin DM; Tanaka Y
    Oncotarget; 2018 Sep; 9(75):34190. PubMed ID: 30344932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correction: c-MET receptor as potential biomarker and target molecule for malignant testicular germ cell tumors.
    Scheri KC; Leonetti E; Laino L; Gigantino V; Gesualdi L; Grammatico P; Bizzarri M; Franco R; Oosterhuis JW; Stoop H; Looijenga LHJ; Ricci G; Catizone A
    Oncotarget; 2018 Nov; 9(89):36049. PubMed ID: 30542519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correction: PPARγ sumoylation-mediated lipid accumulation in lung cancer.
    Phan ANH; Vo VTA; Hua TNM; Kim MK; Jo SY; Choi JW; Kim HW; Son J; Suh YA; Jeong Y
    Oncotarget; 2019 Feb; 10(14):1473. PubMed ID: 30858930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correction: Diagnostic performance enhancement of pancreatic cancer using proteomic multimarker panel.
    Park J; Choi Y; Namkung J; Yi SG; Kim H; Yu J; Kim Y; Kwon MS; Kwon W; Oh DY; Kim SW; Jeong SY; Han W; Lee KE; Heo JS; Park JO; Park JK; Kim SC; Kang CM; Lee WJ; Lee S; Han S; Park T; Jang JY; Kim Y
    Oncotarget; 2018 Jan; 9(4):5514. PubMed ID: 29436532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correction: Halofuginone inhibits radiotherapy-induced epithelial-mesenchymal transition in lung cancer.
    Chen Y; Liu W; Wang P; Hou H; Liu N; Gong L; Wang Y; Ji K; Zhao L; Wang P
    Oncotarget; 2018 Aug; 9(60):31787. PubMed ID: 30167094
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correction: ABL kinase inhibition sensitizes primary lung adenocarcinomas to chemotherapy by promoting tumor cell differentiation.
    Khatri A; Gu JJ; McKernan CM; Xu X; Pendergast AM
    Oncotarget; 2019 Oct; 10(57):6045-6046. PubMed ID: 31666936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correction: Caveolin-1-mediated STAT3 activation determines electrotaxis of human lung cancer cells.
    Li L; Zhang K; Lu C; Sun Q; Zhao S; Jiao L; Han R; Lin C; Jiang J; Zhao M; He Y
    Oncotarget; 2018 Jun; 9(46):28291. PubMed ID: 29963279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correction: Identification of novel gene expression signature in lung adenocarcinoma by using next-generation sequencing data and bioinformatics analysis.
    Hsu YL; Hung JY; Lee YL; Chen FW; Chang KF; Chang WA; Tsai YM; Chong IW; Kuo PL
    Oncotarget; 2019 Jan; 10(5):616. PubMed ID: 30728912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correction: The outcomes and prognostic factors of acute respiratory failure in the patients 90 years old and over.
    Chen WL; Chen CM; Kung SC; Wang CM; Lai CC; Chao CM
    Oncotarget; 2018 Mar; 9(21):15817. PubMed ID: 29645015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correction: Lung cancer susceptibility from
    Yu P; Kusuma JD; Suarez MAR; Shiao SPK
    Oncotarget; 2018 Nov; 9(90):36251. PubMed ID: 30546841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correction: Regulation of Aldo-keto-reductase family 1 B10 by 14-3-3ε and their prognostic impact of hepatocellular carcinoma.
    Liu TA; Jan YJ; Ko BS; Wu YJ; Lu YJ; Liang SM; Liu CC; Chen SC; Wang J; Shyue SK; Liou JY
    Oncotarget; 2018 Oct; 9(79):35026. PubMed ID: 30405891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correction: Role of novel histone modifications in cancer.
    Shanmugam MK; Arfuso F; Arumugam S; Chinnathambi A; Bian J; Warrier S; Wang LZ; Kumar AP; Ahn KS; Sethi G; Lakshmanan M
    Oncotarget; 2018 Apr; 9(27):19460. PubMed ID: 29722359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correction: Lung cancer stem cells and their aggressive progeny, controlled by EGFR/MIG6 inverse expression, dictate a novel NSCLC treatment approach.
    Xiao Z; Sperl B; Gärtner S; Nedelko T; Stacher-Priehse E; Ullrich A; Knyazev PG
    Oncotarget; 2021 Aug; 12(17):1734-1735. PubMed ID: 34434503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correction: Oncogenomics of c-Myc transgenic mice reveal novel regulators of extracellular signaling, angiogenesis and invasion with clinical significance for human lung adenocarcinoma.
    Ciribilli Y; Borlak J
    Oncotarget; 2018 Dec; 9(98):37269. PubMed ID: 30647859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correction: CAPN1 is a novel binding partner and regulator of the tumor suppressor NF1 in melanoma.
    Alon M; Arafeh R; Lee JS; Madan S; Kalaora S; Nagler A; Abgarian T; Greenberg P; Ruppin E; Samuels Y
    Oncotarget; 2019 Feb; 10(13):1344. PubMed ID: 30863494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correction: MiR-451 as a new tumor marker for gastric cancer.
    Shen Y; Gong JM; Zhou LL; Sheng JH
    Oncotarget; 2019 Oct; 10(59):6396. PubMed ID: 31695848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correction: Cancer therapeutic approach based on conformational stabilization of mutant p53 protein by small peptides.
    Tal P; Eizenberger S; Cohen E; Goldfinger N; Pietrokovski S; Oren M; Rotter V
    Oncotarget; 2019 May; 10(34):3203-3206. PubMed ID: 31191814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.